data_1rof_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rof _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.676 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.46 ' OD2' ' HB1' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' HB1' ' OD2' ' A' ' 6' ' ' ASP . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.562 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.661 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' CG2' ' HD2' ' A' ' 2' ' ' LYS . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HB2' HG23 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.591 ' CG2' ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.577 ' O ' ' C ' ' A' ' 54' ' ' GLY . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.676 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 . . . . . 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.632 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' CD ' ' CG2' ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 33' ' ' LYS . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.508 ' OD2' ' CB ' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.508 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 12' ' ' GLY . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.592 ' OG1' ' CG1' ' A' ' 23' ' ' VAL . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.588 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.607 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 54' ' ' GLY . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.1 mt-10 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.652 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.614 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.501 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.3 p30 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' PHE . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 41' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.611 ' HA ' ' HG ' ' A' ' 35' ' ' LEU . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.521 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.607 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' CB ' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.475 ' HB3' HG12 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.54 ' N ' HG13 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.554 ' CG2' ' HA ' ' A' ' 10' ' ' CYS . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.614 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.652 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.628 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HE2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.497 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.548 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.555 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.8 p30 -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.595 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.559 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 24' ' ' PHE . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.653 ' CE1' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.587 ' HB2' ' CA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.569 ' CB ' HG12 ' A' ' 23' ' ' VAL . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.417 ' C ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.553 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.602 ' O ' ' C ' ' A' ' 54' ' ' GLY . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.559 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.628 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.632 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.506 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.506 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 53' ' ' THR . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 50' ' ' SER . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.579 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.738 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.491 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 24' ' ' PHE . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.771 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.595 HG23 ' CE ' ' A' ' 2' ' ' LYS . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.59 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.567 ' O ' ' C ' ' A' ' 54' ' ' GLY . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 . . . . . 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.611 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.583 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG1' ' CB ' ' A' ' 33' ' ' LYS . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' THR . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.527 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.611 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.563 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' ' N ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.704 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' O ' HD22 ' A' ' 35' ' ' LEU . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.545 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.645 HG12 ' CD1' ' A' ' 24' ' ' PHE . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.645 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 9.4 tt0 . . . . . 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.258 0.551 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' CB ' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.556 ' HB ' ' CB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.594 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.571 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.617 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.587 ' CE ' ' HB ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB1' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HA ' HG23 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.591 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 10.4 p30 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.572 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.604 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.537 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.58 ' O ' ' CG2' ' A' ' 39' ' ' THR . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.517 ' N ' HG12 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 54' ' ' GLY . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.658 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.608 ' HE2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.507 ' N ' HG21 ' A' ' 5' ' ' VAL . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HA ' HG22 ' A' ' 53' ' ' THR . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.563 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.618 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.7 p30 -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 24' ' ' PHE . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' CB ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.604 HG13 HD23 ' A' ' 41' ' ' LEU . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.287 0.565 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' HG23 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.599 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.604 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.549 ' O ' ' C ' ' A' ' 54' ' ' GLY . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.608 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.658 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.634 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.507 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB3' ' CE ' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' CA ' HG23 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.5 p30 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.624 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' OG1' ' A' ' 39' ' ' THR . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' HZ ' ' N ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' CE ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.57 ' CG2' HG21 ' A' ' 23' ' ' VAL . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.586 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.601 ' OG1' ' CG1' ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.64 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.52 ' N ' HG12 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.57 HG21 ' CB ' ' A' ' 55' ' ' ALA . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' CB ' HG21 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.567 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.634 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.65 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.589 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.555 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.492 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HA ' HG23 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 12' ' ' GLY . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.794 HD13 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.736 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.548 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.624 HG13 ' CD2' ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 tt0 . . . . . 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.607 ' HB ' ' CB ' ' A' ' 23' ' ' VAL . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.624 ' CD2' HG13 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.594 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.629 ' CB ' ' CE2' ' A' ' 24' ' ' PHE . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.676 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.46 ' OD2' ' HB1' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' HB1' ' OD2' ' A' ' 6' ' ' ASP . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.67 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.661 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' CG2' ' HD2' ' A' ' 2' ' ' LYS . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -144.98 -152.29 0.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 27' ' ' GLY . 2.5 pp -150.03 175.68 11.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.857 . . . . 0.0 109.529 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -121.15 -159.36 10.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.71 -32.67 12.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -1.15 . . . . 0.0 109.415 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.71 -11.09 32.29 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.281 -0.887 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.21 -48.06 1.23 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -44.11 119.35 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -1.1 . . . . 0.0 109.457 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HB2' HG23 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.591 ' CG2' ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HD2' ' S3 ' ' A' ' 61' ' ' SF4 . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.589 HG23 ' S3 ' ' A' ' 61' ' ' SF4 . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.676 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 -111.37 43.62 1.46 Allowed 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.75 -178.221 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.67 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.632 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' CD ' ' CG2' ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 33' ' ' LYS . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' OD2' ' CB ' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 12' ' ' GLY . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.545 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -149.05 -158.32 0.91 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.0 pp -150.94 143.48 24.34 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.5 30.88 0.07 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -80.83 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.113 -1.228 . . . . 0.0 109.707 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.76 -6.4 14.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.234 -0.917 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.11 -15.33 8.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.23 -170.01 1.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -1.147 . . . . 0.0 109.06 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.69 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.592 ' OG1' ' CG1' ' A' ' 23' ' ' VAL . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.588 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.607 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.596 HG23 ' S3 ' ' A' ' 61' ' ' SF4 . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.1 mt-10 -122.79 -50.72 1.94 Allowed 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.78 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.69 ' S4 ' ' CB ' ' A' ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.652 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.614 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.501 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 12' ' ' GLY . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.665 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.3 p30 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' PHE . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' HD21 ' A' ' 41' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.611 ' HA ' ' HG ' ' A' ' 35' ' ' LEU . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 1.6 mt-30 -150.33 104.77 3.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.557 ' CD2' ' CB ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -140.48 171.25 14.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.13 44.01 0.02 OUTLIER Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.51 -91.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -87.18 35.79 0.71 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 -12.76 67.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -87.31 146.32 25.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -1.204 . . . . 0.0 109.341 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.521 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.607 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' CB ' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.475 ' HB3' HG12 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.54 ' N ' HG13 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.615 ' OG1' ' S3 ' ' A' ' 61' ' ' SF4 . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.614 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.652 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -119.78 48.71 1.49 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HB2' HG21 ' A' ' 58' ' ' VAL . 3.4 mt-10 . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.695 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.665 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.628 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HE2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.497 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.548 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.681 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.8 p30 -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.595 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.559 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 24' ' ' PHE . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.653 ' CE1' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -145.81 -153.99 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -150.63 -159.37 1.02 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -131.95 -131.56 3.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.33 -29.76 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -1.189 . . . . 0.0 109.608 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.77 -14.91 60.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.02 -35.5 4.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -43.7 138.34 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 109.202 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.613 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.587 ' HB2' ' CA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.569 ' CB ' HG12 ' A' ' 23' ' ' VAL . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.417 ' C ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.553 ' SG ' ' CG2' ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' S3 ' ' A' ' 61' ' ' SF4 . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.602 ' O ' ' C ' ' A' ' 54' ' ' GLY . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.559 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.628 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER -132.72 -53.16 0.93 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.732 177.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.681 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.632 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.506 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.506 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 53' ' ' THR . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.651 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.579 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD13 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.738 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.491 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 24' ' ' PHE . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.771 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -143.15 91.41 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -149.91 124.13 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.372 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 31' ' ' LYS . . . 173.99 34.37 0.04 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -60.77 -73.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 51.7 t0 -75.15 -24.46 57.94 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.54 -13.2 1.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -83.07 139.56 33.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 109.129 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.595 HG23 ' CE ' ' A' ' 2' ' ' LYS . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.59 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.649 HG22 ' S3 ' ' A' ' 61' ' ' SF4 . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 -116.87 55.93 0.82 Allowed 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.748 -177.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.651 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.611 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.583 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG1' ' CB ' ' A' ' 33' ' ' LYS . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' THR . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.653 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.611 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.563 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.704 ' HG ' ' N ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.704 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' O ' HD22 ' A' ' 35' ' ' LEU . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.545 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.645 HG12 ' CD1' ' A' ' 24' ' ' PHE . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.645 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 9.4 tt0 -126.53 -142.74 0.29 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.86 122.85 13.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.053 . . . . 0.0 109.632 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.92 -157.79 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -111.02 -32.87 6.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -1.121 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -64.92 -30.0 70.97 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.18 -34.75 2.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 137.89 53.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -1.142 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' CB ' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.556 ' HB ' ' CB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.594 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.571 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB1' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.701 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -119.47 -50.67 2.32 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.718 177.604 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.701 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.617 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.587 ' CE ' ' HB ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB1' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HA ' HG23 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.672 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.591 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 10.4 p30 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.572 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.604 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' ' HB2' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.537 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.39 94.55 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 27' ' ' GLY . 39.8 tp -133.03 -88.67 0.42 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.187 -0.945 . . . . 0.0 109.162 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 40.15 39.32 1.51 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -80.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.079 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.46 -18.9 58.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.329 -0.857 . . . . 0.0 109.305 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 -28.86 1.08 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -74.05 127.31 32.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -1.115 . . . . 0.0 109.364 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.58 ' O ' ' CG2' ' A' ' 39' ' ' THR . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.61 HD23 ' CE1' ' A' ' 24' ' ' PHE . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.517 ' N ' HG12 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.69 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.617 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -116.68 58.11 0.77 Allowed 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 1.8 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.753 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.69 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.658 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.608 ' HE2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.507 ' N ' HG21 ' A' ' 5' ' ' VAL . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HA ' HG22 ' A' ' 53' ' ' THR . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.674 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.618 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.7 p30 -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 24' ' ' PHE . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' CB ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.604 HG13 HD23 ' A' ' 41' ' ' LEU . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 -145.2 -148.43 0.24 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -109.18 166.67 10.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.52 -114.13 3.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -102.22 -38.34 7.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -1.156 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -164.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.35 -31.93 3.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.22 125.8 18.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -1.175 . . . . 0.0 109.643 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' HG23 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.599 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.604 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' A' ' 1' ' ' MET . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.472 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.684 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.608 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.658 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.41 -54.57 2.57 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.744 177.681 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.684 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.634 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' CD ' ' HB ' ' A' ' 56' ' ' ILE . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.507 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB3' ' CE ' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' CA ' HG23 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.671 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.5 p30 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.624 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' OG1' ' A' ' 39' ' ' THR . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' HZ ' ' N ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -149.4 113.98 5.3 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -139.43 -79.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 41.75 36.01 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' HD11 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -56.23 -64.82 0.74 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 109.508 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -125.13 32.98 5.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.58 -29.21 8.79 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' CE ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -86.73 134.36 33.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 109.292 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.57 ' CG2' HG21 ' A' ' 23' ' ' VAL . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.586 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.601 ' OG1' ' CG1' ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.64 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.52 ' N ' HG12 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.631 ' OG1' ' S3 ' ' A' ' 61' ' ' SF4 . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' CB ' HG21 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CD ' ' A' ' 2' ' ' LYS . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.567 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.634 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -93.29 -43.4 8.82 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' CB ' HG22 ' A' ' 3' ' ' VAL . 1.7 tp10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.747 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.671 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.65 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.589 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.555 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.492 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HA ' HG23 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 12' ' ' GLY . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.659 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.794 HD13 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.736 ' HB2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.548 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.624 HG13 ' CD2' ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 tt0 -129.79 -144.78 0.27 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 pp -138.6 173.63 11.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.76 155.64 15.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -63.97 -41.07 97.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -13.63 54.32 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.55 -39.4 2.9 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -55.09 120.36 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -1.09 . . . . 0.0 109.462 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.45 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' A' ' 36' ' ' GLN . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.607 ' HB ' ' CB ' ' A' ' 23' ' ' VAL . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.624 ' CD2' HG13 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.594 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' N ' ' HZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.629 ' CB ' ' CE2' ' A' ' 24' ' ' PHE . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.692 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -108.18 -65.35 1.13 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.865 177.37 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SF4 . . . . . 0.692 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.969 ' HE3' HG21 ' A' ' 39' ' ' THR . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 33' ' ' LYS . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.45 ' C ' ' OG1' ' A' ' 53' ' ' THR . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.667 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.004 HG12 HD21 ' A' ' 41' ' ' LEU . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.726 HD11 ' NE2' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.726 ' NE2' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.969 HG21 ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.004 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.932 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.932 HG22 ' SG ' ' A' ' 51' ' ' CYS . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.792 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.87 HG21 ' HZ3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 . . . . . 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.68 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' CD ' HG21 ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 11' ' ' ILE . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.1 p-10 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.742 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.694 ' CB ' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.954 HG12 HD21 ' A' ' 41' ' ' LEU . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 2.3 mt-30 . . . . . 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.735 HG21 ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.637 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 39' ' ' THR . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' CE ' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.403 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.96 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.96 HG22 ' SG ' ' A' ' 51' ' ' CYS . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.858 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.561 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.68 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.1 mt-10 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.698 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.833 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 59' ' ' GLU . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 34' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.738 ' HB1' ' HG3' ' A' ' 31' ' ' LYS . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.019 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.55 HG11 ' N ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.55 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.0 p-10 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 47' ' ' ALA . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.697 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.779 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.738 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.019 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 5' ' ' VAL . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.833 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.747 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.88 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' HG11 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.991 HG21 ' HA ' ' A' ' 10' ' ' CYS . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.622 HG22 ' HB ' ' A' ' 34' ' ' VAL . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.645 ' CB ' HG21 ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.665 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.741 ' HE3' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.614 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 36' ' ' GLN . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.741 HG22 ' HE3' ' A' ' 2' ' ' LYS . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.68 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.434 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.017 ' SG ' HG22 ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.017 HG22 ' SG ' ' A' ' 51' ' ' CYS . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.625 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.795 ' HE1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.778 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HG2' ' NH1' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.965 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 18' ' ' ASN . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.871 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.991 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.896 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.82 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.029 HG12 HD21 ' A' ' 41' ' ' LEU . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.991 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.965 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.82 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.64 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.833 ' OG1' HG11 ' A' ' 23' ' ' VAL . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.029 HD21 HG12 ' A' ' 23' ' ' VAL . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.763 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 ' HA ' ' A' ' 10' ' ' CYS . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 34' ' ' VAL . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.697 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 . . . . . 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.654 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.956 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.089 HG22 HG12 ' A' ' 34' ' ' VAL . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HA ' HG21 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.032 ' C ' HD22 ' A' ' 18' ' ' ASN . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 1.032 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.708 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.84 ' HB3' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.103 ' CG1' HD21 ' A' ' 41' ' ' LEU . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.871 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 2.3 tt0 . . . . . 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.258 0.551 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.971 ' CB ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.089 HG12 HG22 ' A' ' 5' ' ' VAL . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.956 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.103 HD21 ' CG1' ' A' ' 23' ' ' VAL . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.718 ' HB2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.702 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.647 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.611 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.2 p-10 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.659 ' HB2' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG12 HD21 ' A' ' 41' ' ' LEU . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 5' ' ' VAL . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.85 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.716 HG21 ' HB2' ' A' ' 44' ' ' ALA . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 HG12 ' A' ' 23' ' ' VAL . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.535 ' N ' HG11 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 54' ' ' GLY . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.683 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.83 ' HD2' HG21 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 10' ' ' CYS . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.564 HG11 ' N ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.642 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' O ' HD21 ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.287 0.565 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.902 ' CB ' HG21 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 5' ' ' VAL . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.648 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' THR . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.608 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.564 ' N ' HG11 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.549 ' O ' ' C ' ' A' ' 54' ' ' GLY . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.657 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.806 ' HZ2' HG21 ' A' ' 39' ' ' THR . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.593 ' CA ' HG21 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG11 ' N ' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.5 p-10 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.804 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.951 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.954 ' HB ' HG22 ' A' ' 56' ' ' ILE . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.621 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.874 ' OG1' HG11 ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.849 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 15' ' ' VAL . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.568 ' N ' HG11 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.994 HG22 ' HB2' ' A' ' 55' ' ' ALA . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.994 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.954 HG22 ' HB ' ' A' ' 34' ' ' VAL . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.718 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.692 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.981 ' HE2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 57' ' ' SER . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.573 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' ASP . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.489 ' HA ' HG21 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 11' ' ' ILE . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.951 ' C ' HD22 ' A' ' 18' ' ' ASN . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.951 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.881 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.068 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 1.03 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 5' ' ' VAL . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.768 HD11 ' OE1' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.768 ' OE1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.981 HG21 ' HE2' ' A' ' 2' ' ' LYS . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.068 HD21 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.654 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.493 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 ' HD3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.875 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.692 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.833 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.969 ' HE3' HG21 ' A' ' 39' ' ' THR . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 33' ' ' LYS . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.45 ' C ' ' OG1' ' A' ' 53' ' ' THR . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.709 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.667 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.004 HG12 HD21 ' A' ' 41' ' ' LEU . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -144.98 -152.29 0.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 27' ' ' GLY . 2.5 pp -150.03 175.68 11.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.857 . . . . 0.0 109.529 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -121.15 -159.36 10.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.71 -32.67 12.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -1.15 . . . . 0.0 109.415 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.71 -11.09 32.29 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.281 -0.887 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.21 -48.06 1.23 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -44.11 119.35 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -1.1 . . . . 0.0 109.457 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.726 HD11 ' NE2' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.726 ' NE2' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.969 HG21 ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.004 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.932 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.932 HG22 ' SG ' ' A' ' 51' ' ' CYS . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.792 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.87 HG21 ' HZ3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 -111.37 43.62 1.46 Allowed 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.75 -178.221 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.709 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.68 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' CD ' HG21 ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 11' ' ' ILE . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.696 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.1 p-10 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.742 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.694 ' CB ' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.954 HG12 HD21 ' A' ' 41' ' ' LEU . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 2.3 mt-30 -149.05 -158.32 0.91 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.0 pp -150.94 143.48 24.34 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.5 30.88 0.07 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -80.83 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.113 -1.228 . . . . 0.0 109.707 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.76 -6.4 14.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.234 -0.917 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.11 -15.33 8.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.23 -170.01 1.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -1.147 . . . . 0.0 109.06 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.69 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.735 HG21 ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.637 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 39' ' ' THR . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' CE ' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.403 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.96 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.96 HG22 ' SG ' ' A' ' 51' ' ' CYS . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.858 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.561 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.68 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.1 mt-10 -122.79 -50.72 1.94 Allowed 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.78 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.696 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.698 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.833 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 59' ' ' GLU . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 34' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.738 ' HB1' ' HG3' ' A' ' 31' ' ' LYS . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.019 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.701 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.55 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.0 p-10 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 47' ' ' ALA . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.697 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.779 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.93 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.6 mt-30 -150.33 104.77 3.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.93 HD22 ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -140.48 171.25 14.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.13 44.01 0.02 OUTLIER Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.51 -91.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -87.18 35.79 0.71 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 -12.76 67.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.738 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -87.31 146.32 25.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -1.204 . . . . 0.0 109.341 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.019 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 5' ' ' VAL . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.833 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.747 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.88 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' HG11 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.991 HG21 ' HA ' ' A' ' 10' ' ' CYS . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.622 HG22 ' HB ' ' A' ' 34' ' ' VAL . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.645 ' CB ' HG21 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -119.78 48.71 1.49 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 3.4 mt-10 . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.695 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.701 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.665 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.741 ' HE3' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.712 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 36' ' ' GLN . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -145.81 -153.99 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.63 -159.37 1.02 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.95 -131.56 3.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.33 -29.76 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -1.189 . . . . 0.0 109.608 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.77 -14.91 60.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.02 -35.5 4.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -43.7 138.34 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 109.202 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.741 HG22 ' HE3' ' A' ' 2' ' ' LYS . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.68 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.434 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.017 ' SG ' HG22 ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' HD2' ' S3 ' ' A' ' 61' ' ' SF4 . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.017 HG22 ' SG ' ' A' ' 51' ' ' CYS . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.625 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -132.72 -53.16 0.93 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.732 177.569 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.712 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.795 ' HE1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.778 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HG2' ' NH1' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.965 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 18' ' ' ASN . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.871 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.991 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.896 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.82 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.029 HG12 HD21 ' A' ' 41' ' ' LEU . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.991 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -143.15 91.41 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -149.91 124.13 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.372 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 31' ' ' LYS . . . 173.99 34.37 0.04 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -60.77 -73.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 51.7 t0 -75.15 -24.46 57.94 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.54 -13.2 1.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -83.07 139.56 33.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 109.129 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.965 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.82 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.64 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.833 ' OG1' HG11 ' A' ' 23' ' ' VAL . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.029 HD21 HG12 ' A' ' 23' ' ' VAL . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.763 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 ' HA ' ' A' ' 10' ' ' CYS . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 34' ' ' VAL . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.697 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 -116.87 55.93 0.82 Allowed 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.748 -177.834 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.671 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.654 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.956 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.089 HG22 HG12 ' A' ' 34' ' ' VAL . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HA ' HG21 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.032 ' C ' HD22 ' A' ' 18' ' ' ASN . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 1.032 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.708 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.84 ' HB3' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.103 ' CG1' HD21 ' A' ' 41' ' ' LEU . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.871 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 2.3 tt0 -126.53 -142.74 0.29 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -142.86 122.85 13.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.053 . . . . 0.0 109.632 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 26' ' ' LEU . . . -63.92 -157.79 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -111.02 -32.87 6.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -1.121 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -64.92 -30.0 70.97 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.18 -34.75 2.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 137.89 53.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -1.142 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.971 ' CB ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.089 HG12 HG22 ' A' ' 5' ' ' VAL . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.956 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.103 HD21 ' CG1' ' A' ' 23' ' ' VAL . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.718 ' HB2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.702 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.701 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.647 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -119.47 -50.67 2.32 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.718 177.604 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.701 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.711 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.611 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.2 p-10 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.659 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG12 HD21 ' A' ' 41' ' ' LEU . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.39 94.55 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 33' ' ' LYS . 39.8 tp -133.03 -88.67 0.42 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.187 -0.945 . . . . 0.0 109.162 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 40.15 39.32 1.51 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -80.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.079 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.46 -18.9 58.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.329 -0.857 . . . . 0.0 109.305 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 -28.86 1.08 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -74.05 127.31 32.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -1.115 . . . . 0.0 109.364 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 5' ' ' VAL . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.85 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.716 HG21 ' HB2' ' A' ' 44' ' ' ALA . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 HG12 ' A' ' 23' ' ' VAL . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.535 ' N ' HG11 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.69 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -116.68 58.11 0.77 Allowed 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 1.8 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.753 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.711 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.683 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.83 ' HD2' HG21 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 10' ' ' CYS . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.711 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.642 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' O ' HD21 ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 -145.2 -148.43 0.24 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -109.18 166.67 10.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.52 -114.13 3.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -102.22 -38.34 7.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -1.156 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -124.93 -164.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.35 -31.93 3.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -53.22 125.8 18.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -1.175 . . . . 0.0 109.643 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.902 ' CB ' HG21 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 5' ' ' VAL . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.648 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' THR . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.608 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.564 ' N ' HG11 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.684 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.41 -54.57 2.57 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.744 177.681 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.711 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.657 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.806 ' HZ2' HG21 ' A' ' 39' ' ' THR . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 60' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.593 ' CA ' HG21 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.708 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 19' ' ' LEU . 1.5 p-10 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.804 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.951 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -149.4 113.98 5.3 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -139.43 -79.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 41.75 36.01 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -64.82 0.74 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -125.13 32.98 5.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.58 -29.21 8.79 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.73 134.36 33.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 109.292 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.954 ' HB ' HG22 ' A' ' 56' ' ' ILE . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.621 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.874 ' OG1' HG11 ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.849 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 15' ' ' VAL . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.568 ' N ' HG11 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.994 HG22 ' HB2' ' A' ' 55' ' ' ALA . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.994 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.954 HG22 ' HB ' ' A' ' 34' ' ' VAL . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.718 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -93.29 -43.4 8.82 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 3' ' ' VAL . 1.7 tp10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.747 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.708 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.692 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.981 ' HE2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 57' ' ' SER . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.573 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' ASP . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.489 ' HA ' HG21 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 11' ' ' ILE . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.951 ' C ' HD22 ' A' ' 18' ' ' ASN . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.951 HD22 ' C ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.881 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.068 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 1.03 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 3.4 tt0 -129.79 -144.78 0.27 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 26' ' ' LEU . 2.0 pp -138.6 173.63 11.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.76 155.64 15.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -63.97 -41.07 97.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -13.63 54.32 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.55 -39.4 2.9 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.09 120.36 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -1.09 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 5' ' ' VAL . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.768 HD11 ' OE1' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.768 ' OE1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.981 HG21 ' HE2' ' A' ' 2' ' ' LYS . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.068 HD21 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.654 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.493 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' S3 ' ' A' ' 61' ' ' SF4 . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 ' HD3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.875 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.692 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.833 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -108.18 -65.35 1.13 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.865 177.37 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SF4 . . . . . 0.787 ' S3 ' HG21 ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.969 ' HE3' HG21 ' A' ' 39' ' ' THR . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 33' ' ' LYS . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.45 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.667 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.004 HG12 HD21 ' A' ' 41' ' ' LEU . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.678 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.969 HG21 ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.004 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.932 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.932 HG22 ' SG ' ' A' ' 51' ' ' CYS . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.792 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.87 HG21 ' HZ3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 . . . . . 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.68 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.735 ' CD ' HG21 ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 11' ' ' ILE . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.742 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.694 ' CB ' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.954 HG12 HD21 ' A' ' 41' ' ' LEU . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.735 HG21 ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.637 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 39' ' ' THR . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' CE ' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.403 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.96 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.96 HG22 ' SG ' ' A' ' 51' ' ' CYS . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.858 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.561 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.68 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.1 mt-10 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.698 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.833 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 59' ' ' GLU . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 34' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.738 ' HB1' ' HG3' ' A' ' 31' ' ' LYS . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.019 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.55 HG11 ' N ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.55 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.3 p30 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 47' ' ' ALA . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.697 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.779 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.738 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.019 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 5' ' ' VAL . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.833 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.747 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.88 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' HG11 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.991 HG21 ' HA ' ' A' ' 10' ' ' CYS . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.622 HG22 ' HB ' ' A' ' 34' ' ' VAL . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.645 ' CB ' HG21 ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.665 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.741 ' HE3' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.8 p30 -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.614 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 36' ' ' GLN . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.741 HG22 ' HE3' ' A' ' 2' ' ' LYS . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.68 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.434 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.017 ' SG ' HG22 ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.017 HG22 ' SG ' ' A' ' 51' ' ' CYS . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.625 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.795 ' HE1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.778 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.965 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 50' ' ' SER . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.991 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.896 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.82 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.029 HG12 HD21 ' A' ' 41' ' ' LEU . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.991 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.965 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.82 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.64 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.833 ' OG1' HG11 ' A' ' 23' ' ' VAL . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.029 HD21 HG12 ' A' ' 23' ' ' VAL . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.763 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 ' HA ' ' A' ' 10' ' ' CYS . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 34' ' ' VAL . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.697 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 . . . . . 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.654 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.956 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.089 HG22 HG12 ' A' ' 34' ' ' VAL . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HA ' HG21 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.527 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.563 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.708 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HB2' ' NE2' ' A' ' 25' ' ' GLN . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.84 ' HB3' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.103 ' CG1' HD21 ' A' ' 41' ' ' LEU . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.871 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 9.4 tt0 . . . . . 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.258 0.551 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.971 ' CB ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.089 HG12 HG22 ' A' ' 5' ' ' VAL . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.956 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.103 HD21 ' CG1' ' A' ' 23' ' ' VAL . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.718 ' HB2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.702 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.647 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.536 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.611 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 10.4 p30 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.659 ' HB2' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG12 HD21 ' A' ' 41' ' ' LEU . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 5' ' ' VAL . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.85 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.716 HG21 ' HB2' ' A' ' 44' ' ' ALA . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 HG12 ' A' ' 23' ' ' VAL . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.535 ' N ' HG11 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 54' ' ' GLY . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.683 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.83 ' HD2' HG21 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 10' ' ' CYS . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.7 p30 -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' O ' HD21 ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 . . . . . 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.287 0.565 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.902 ' CB ' HG21 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 5' ' ' VAL . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.648 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' THR . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.608 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.564 ' N ' HG11 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.549 ' O ' ' C ' ' A' ' 54' ' ' GLY . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.657 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.806 ' HZ2' HG21 ' A' ' 39' ' ' THR . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.593 ' CA ' HG21 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG11 ' N ' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.5 p30 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.804 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.951 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.954 ' HB ' HG22 ' A' ' 56' ' ' ILE . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.621 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.874 ' OG1' HG11 ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.849 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 15' ' ' VAL . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.568 ' N ' HG11 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.994 HG22 ' HB2' ' A' ' 55' ' ' ALA . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.994 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.954 HG22 ' HB ' ' A' ' 34' ' ' VAL . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 58' ' ' VAL . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.692 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.981 ' HE2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 57' ' ' SER . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.573 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' ASP . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.489 ' HA ' HG21 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 11' ' ' ILE . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 15' ' ' VAL . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.881 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.068 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 1.03 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 5' ' ' VAL . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.768 HD11 ' OE1' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.768 ' OE1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.981 HG21 ' HE2' ' A' ' 2' ' ' LYS . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.068 HD21 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.654 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.493 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' C ' ' A' ' 54' ' ' GLY . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 ' HD3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.875 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.692 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.833 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 58' ' ' VAL . 8.7 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 122.105 0.955 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.969 ' HE3' HG21 ' A' ' 39' ' ' THR . 9.8 ttmt -162.68 54.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.37 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 2.2 t -89.45 -27.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.315 -1.491 . . . . 0.0 109.797 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -99.61 108.65 21.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.993 -1.067 . . . . 0.0 108.541 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 33' ' ' LYS . 7.3 p -95.7 137.01 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 110.322 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 9' ' ' ALA . 36.5 t0 -108.41 105.93 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.441 -0.787 . . . . 0.0 109.071 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.15 -63.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.404 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -44.92 -26.25 0.39 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.558 -0.713 . . . . 0.0 109.567 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.45 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -79.94 -49.89 11.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 110.084 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.754 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.4 t -42.13 149.54 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 109.846 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -133.15 39.4 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.47 71.33 0.18 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -107.5 -46.83 3.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.25 . . . . 0.0 110.243 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.99 1.01 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.709 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.39 -5.37 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -1.056 . . . . 0.0 109.139 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p -102.33 -58.0 1.96 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 110.775 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -43.98 -40.54 4.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.146 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -66.97 -46.41 74.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 108.675 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.46 -77.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.832 0.825 . . . . 0.0 110.234 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.8 136.38 9.3 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.49 -15.2 41.38 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 123.962 3.108 . . . . 0.0 111.322 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.667 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -64.08 -59.77 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 111.0 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.004 HG12 HD21 ' A' ' 41' ' ' LEU . 5.0 p -122.11 -26.73 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 110.923 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -97.58 95.09 7.37 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.643 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -144.98 -152.29 0.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.222 -0.924 . . . . 0.0 108.916 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 27' ' ' GLY . 2.5 pp -150.03 175.68 11.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.857 . . . . 0.0 109.529 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -121.15 -159.36 10.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.71 -32.67 12.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -1.15 . . . . 0.0 109.415 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.71 -11.09 32.29 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.281 -0.887 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.21 -48.06 1.23 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -44.11 119.35 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -1.1 . . . . 0.0 109.457 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -98.36 89.42 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' HG21 ' A' ' 5' ' ' VAL . 34.8 pttt -105.36 -169.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.629 ' CG2' ' CD ' ' A' ' 2' ' ' LYS . 14.8 p -83.04 144.28 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.678 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -105.79 -37.23 6.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 179.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -106.05 136.36 19.33 Favored Pre-proline 0 N--CA 1.494 1.746 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.244 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.22 -73.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.284 2.656 . . . . 0.0 110.967 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.4 58.11 4.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.076 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.969 HG21 ' HE3' ' A' ' 2' ' ' LYS . 1.8 t -57.61 100.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.17 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -89.33 -16.53 30.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.004 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.5 162.58 0.12 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 109.782 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.4 Cg_endo -84.64 4.64 6.74 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.867 2.378 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.67 -8.99 36.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.869 -1.144 . . . . 0.0 111.266 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.54 -10.99 32.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.521 . . . . 0.0 109.677 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.14 88.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -33.97 39.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.656 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.07 -33.94 12.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.351 -0.843 . . . . 0.0 108.773 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.6 91.73 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.239 -0.913 . . . . 0.0 109.052 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.56 1.14 52.75 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 58.6 m -105.18 -72.16 0.72 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.932 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.1 t -40.45 118.79 1.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.472 -0.767 . . . . 0.0 109.671 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.0 -15.38 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.438 2.092 . . . . 0.0 110.653 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.932 HG22 ' SG ' ' A' ' 51' ' ' CYS . 12.3 t -94.11 5.25 52.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.026 -1.047 . . . . 0.0 109.967 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 32.93 45.05 0.23 Allowed Glycine 0 N--CA 1.503 3.159 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.792 ' CB ' HG23 ' A' ' 53' ' ' THR . . . -90.81 -22.64 20.91 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.351 -176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.87 HG21 ' HZ3' ' A' ' 2' ' ' LYS . 23.7 pt -86.13 89.01 2.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 27.5 t -91.08 136.31 33.17 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.622 -1.299 . . . . 0.0 111.082 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 1' ' ' MET . 2.3 p -85.59 103.08 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 122.977 1.37 . . . . 0.0 110.298 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 3' ' ' VAL . 2.2 mt-10 -111.37 43.62 1.46 Allowed 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.75 -178.221 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.709 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.68 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.643 0.735 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' CD ' HG21 ' A' ' 34' ' ' VAL . 1.3 ttmt -164.39 147.18 9.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.909 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -154.96 -46.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 6.3 ptp85 -115.54 145.81 42.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 p -109.78 118.73 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.0 110.136 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 35.0 t0 -93.07 110.92 22.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 31' ' ' LYS . . . -97.14 -64.94 1.0 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.58 -26.38 0.59 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.509 -0.745 . . . . 0.0 109.628 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -84.3 -38.98 19.75 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.508 -0.745 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' N ' ' OG1' ' A' ' 53' ' ' THR . 10.8 t -53.26 154.83 3.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 11' ' ' ILE . 20.6 tt -140.3 43.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 109.981 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 32.79 45.06 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -73.92 -46.37 44.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.171 -1.194 . . . . 0.0 110.066 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.89 44.81 1.0 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.696 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.43 -5.69 10.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.361 -1.082 . . . . 0.0 109.109 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 3.2 p -104.76 -50.67 3.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.093 -1.004 . . . . 0.0 110.063 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.42 -43.95 34.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.2 p30 -65.64 -45.75 81.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 108.852 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.6 mt -47.6 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.768 0.794 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.742 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -155.94 137.05 9.28 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -177.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 36.2 Cg_endo -69.55 -15.26 37.77 Favored 'Trans proline' 0 C--N 1.295 -2.261 0 C-N-CA 123.97 3.113 . . . . 0.0 111.517 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.694 ' CB ' HD23 ' A' ' 41' ' ' LEU . 1.1 m-20 -64.44 -56.78 11.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 111.398 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.954 HG12 HD21 ' A' ' 41' ' ' LEU . 5.1 p -123.89 -28.65 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.355 -0.841 . . . . 0.0 110.91 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -94.21 78.08 3.99 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.682 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -149.05 -158.32 0.91 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.191 -0.943 . . . . 0.0 108.681 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.0 pp -150.94 143.48 24.34 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.428 -0.795 . . . . 0.0 109.712 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.5 30.88 0.07 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -80.83 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.113 -1.228 . . . . 0.0 109.707 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -111.76 -6.4 14.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.234 -0.917 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.11 -15.33 8.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.23 -170.01 1.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -1.147 . . . . 0.0 109.06 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.69 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -118.13 85.95 2.44 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -110.37 -176.72 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.192 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.735 HG21 ' CD ' ' A' ' 2' ' ' LYS . 10.3 p -81.09 140.36 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.737 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -104.68 -34.46 8.14 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.637 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -104.94 140.74 21.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.666 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.5 Cg_endo -81.02 -78.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.77 2.313 . . . . 0.0 110.213 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.08 58.26 4.71 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.935 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 39' ' ' THR . 4.8 t -54.86 109.07 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -88.95 -16.02 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.202 -0.936 . . . . 0.0 108.609 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 HG12 ' A' ' 23' ' ' VAL . 1.3 pp -41.23 160.9 0.13 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.657 -0.652 . . . . 0.0 109.578 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 39.7 Cg_endo -84.22 6.34 5.81 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.814 2.343 . . . . 0.0 110.049 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.79 -10.73 28.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.782 -178.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.35 -10.48 38.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 119.968 -1.707 . . . . 0.0 109.506 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.62 -45.26 93.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 177.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -34.13 29.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.574 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.38 -32.46 11.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.147 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB2' ' CE ' ' A' ' 1' ' ' MET . . . -58.96 -45.56 90.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.227 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.09 1.29 55.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.478 -0.764 . . . . 0.0 109.73 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.403 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -102.01 -70.56 0.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.711 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.96 ' SG ' HG22 ' A' ' 53' ' ' THR . 43.5 t -49.14 117.1 6.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 0.0 109.625 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.55 -20.73 10.6 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.323 2.015 . . . . 0.0 110.429 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.96 HG22 ' SG ' ' A' ' 51' ' ' CYS . 6.6 t -83.23 7.54 15.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.037 -1.039 . . . . 0.0 110.472 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 31.85 46.57 0.21 Allowed Glycine 0 N--CA 1.505 3.256 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.858 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.37 -13.31 35.31 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.399 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.561 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.5 pt -107.39 78.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.62 119.37 27.85 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.124 -0.985 . . . . 0.0 109.785 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.68 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.0 p -84.29 121.68 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 123.323 1.535 . . . . 0.0 112.037 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.675 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.1 mt-10 -122.79 -50.72 1.94 Allowed 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.78 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.696 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.698 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.698 0.761 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.833 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -166.84 141.1 3.96 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.991 -1.083 . . . . 0.0 111.727 -174.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 59' ' ' GLU . 2.7 t -156.64 -45.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.11 -0.994 . . . . 0.0 108.444 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ttp-105 -105.9 134.89 48.29 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 34' ' ' VAL . 2.7 m -105.64 120.04 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 20.0 t0 -99.59 101.08 12.18 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.902 . . . . 0.0 109.408 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.738 ' HB1' ' HG3' ' A' ' 31' ' ' LYS . . . -86.17 -64.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.94 -30.67 1.05 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -78.55 -48.11 15.89 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.489 -0.757 . . . . 0.0 109.554 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.019 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 17.0 t -42.59 151.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mt -139.51 38.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.091 -1.005 . . . . 0.0 110.215 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.99 53.49 1.53 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 4.9 p -83.21 -42.13 17.62 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.34 46.0 1.19 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.701 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -112.36 -10.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.517 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 5.3 p -105.85 -47.27 3.92 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.906 -1.122 . . . . 0.0 110.89 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 12.5 pt-20 -47.36 -47.2 26.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.309 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.55 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 3.3 p30 -68.15 -41.76 81.09 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.329 -0.857 . . . . 0.0 108.834 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 47' ' ' ALA . 3.9 mt -46.24 -82.8 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.242 -0.911 . . . . 0.0 109.803 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -154.49 141.64 13.54 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.7 Cg_endo -70.94 -15.74 32.64 Favored 'Trans proline' 0 C--N 1.294 -2.307 0 C-N-CA 124.172 3.248 . . . . 0.0 111.529 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.697 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.9 t0 -64.46 -58.66 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 111.274 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.779 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -124.62 -19.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 O-C-N 121.593 -0.692 . . . . 0.0 110.703 -177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -99.88 55.58 0.94 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.61 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.93 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.6 mt-30 -150.33 104.77 3.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 109.856 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.93 HD22 ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -140.48 171.25 14.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.216 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.13 44.01 0.02 OUTLIER Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -74.51 -91.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.685 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -87.18 35.79 0.71 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 -12.76 67.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.738 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -87.31 146.32 25.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -1.204 . . . . 0.0 109.341 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.019 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -123.53 101.72 7.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -121.87 -170.91 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.02 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HG12 ' A' ' 5' ' ' VAL . 8.4 p -74.41 141.91 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -102.86 -35.51 8.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.73 140.45 21.37 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.544 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 37.1 Cg_endo -80.68 -76.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.022 2.481 . . . . 0.0 111.08 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -88.6 54.13 2.94 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.833 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 9.9 t -57.55 98.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.796 -1.162 . . . . 0.0 108.527 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.5 2.13 54.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.747 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -56.93 164.68 2.13 Favored Pre-proline 0 N--CA 1.486 1.349 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.959 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.3 Cg_endo -80.44 4.27 7.0 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.26 1.974 . . . . 0.0 109.985 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.73 -13.88 25.3 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.955 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.88 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.34 -10.49 38.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.415 -1.428 . . . . 0.0 110.051 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -47.08 86.24 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -34.65 41.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.858 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -49.52 -32.3 12.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.071 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.94 87.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.263 -0.898 . . . . 0.0 108.742 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -85.8 -2.78 58.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.46 -0.775 . . . . 0.0 109.279 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.3 m -97.18 -76.98 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' HG11 ' A' ' 15' ' ' VAL . 48.6 t -45.37 103.97 0.37 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.934 -1.104 . . . . 0.0 109.545 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.2 Cg_endo -78.94 6.27 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.424 2.083 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.991 HG21 ' HA ' ' A' ' 10' ' ' CYS . 1.2 p -104.19 9.47 36.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 38.35 40.25 0.89 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.61 -17.44 30.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.344 -0.503 . . . . 0.0 110.072 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.622 HG22 ' HB ' ' A' ' 34' ' ' VAL . 3.3 pt -111.35 82.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.613 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.35 119.43 29.82 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.284 -0.885 . . . . 0.0 110.84 -177.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.2 p -81.97 116.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.24 1.495 . . . . 0.0 111.079 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.645 ' CB ' HG21 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -119.78 48.71 1.49 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 175.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 3.4 mt-10 . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.695 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.701 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.665 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.758 0.79 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.741 ' HE3' HG22 ' A' ' 39' ' ' THR . 0.0 OUTLIER -162.87 148.68 12.18 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.685 -176.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.1 p -155.0 -45.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -117.02 137.07 52.48 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.123 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.7 m -102.02 116.69 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.634 -0.666 . . . . 0.0 109.415 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 21.2 t0 -90.23 87.31 6.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.136 -0.977 . . . . 0.0 109.207 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.9 -62.94 1.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.91 -26.73 0.45 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.243 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -81.48 -41.97 20.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.573 -0.704 . . . . 0.0 109.761 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 19.2 t -43.89 149.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 tt -133.29 39.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.978 . . . . 0.0 110.056 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 36.19 68.4 0.31 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.8 p -103.56 -47.28 4.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.054 -1.263 . . . . 0.0 110.203 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 109.61 44.53 1.05 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.712 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 2.0 t -110.14 -5.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.425 -1.044 . . . . 0.0 109.025 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 3.3 p -103.23 -52.71 2.97 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.907 -1.121 . . . . 0.0 110.23 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -46.49 -42.78 16.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 108.717 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.8 p30 -66.02 -46.26 78.54 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.859 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -46.68 -81.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.853 0.835 . . . . 0.0 109.781 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -153.83 142.11 14.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.59 -15.48 33.97 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 C-N-CA 124.168 3.245 . . . . 0.0 111.221 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -66.52 -57.97 6.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 111.71 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 36' ' ' GLN . 10.4 p -124.81 -12.54 5.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.484 -0.76 . . . . 0.0 110.439 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.5 OUTLIER -107.65 75.87 1.03 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.213 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -145.81 -153.99 0.52 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.056 -1.028 . . . . 0.0 108.773 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.63 -159.37 1.02 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.95 -131.56 3.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.33 -29.76 7.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -1.189 . . . . 0.0 109.608 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.77 -14.91 60.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' LYS . . . 100.02 -35.5 4.73 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -43.7 138.34 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 109.202 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -122.43 93.92 4.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 110.053 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -123.34 -153.06 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 108.709 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.1 p -89.42 137.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.95 -1.094 . . . . 0.0 109.799 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -103.51 -33.56 9.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.68 136.99 19.91 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.359 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.0 Cg_endo -78.61 -73.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 122.739 2.292 . . . . 0.0 110.634 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 6.1 mm-40 -88.94 57.09 3.97 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.862 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.741 HG22 ' HE3' ' A' ' 2' ' ' LYS . 5.7 t -55.21 108.44 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.673 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -88.67 -20.68 24.57 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.079 -1.013 . . . . 0.0 108.282 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.68 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 1.1 pp -42.04 160.65 0.17 Allowed Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.671 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -84.77 6.12 5.9 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.721 2.281 . . . . 0.0 109.493 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -89.71 -14.07 35.52 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.196 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.23 -15.26 27.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.314 -1.491 . . . . 0.0 110.508 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 0.2 OUTLIER -59.33 -47.31 85.87 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.07 -35.91 56.3 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.793 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -45.11 -35.12 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.93 83.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.3 -0.86 51.52 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.443 -0.786 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.434 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -105.28 -73.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.785 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.017 ' SG ' HG22 ' A' ' 53' ' ' THR . 41.3 t -43.3 121.47 3.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' HD2' ' S3 ' ' A' ' 61' ' ' SF4 . 35.8 Cg_endo -78.02 -23.7 8.95 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.327 2.018 . . . . 0.0 109.806 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.017 HG22 ' SG ' ' A' ' 51' ' ' CYS . 4.4 t -84.54 0.61 49.28 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.35 -0.844 . . . . 0.0 109.759 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.44 50.37 0.19 Allowed Glycine 0 N--CA 1.505 3.299 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 53' ' ' THR . . . -90.26 2.37 55.52 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 122.329 -0.512 . . . . 0.0 110.626 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CG2' ' HD3' ' A' ' 2' ' ' LYS . 1.7 pt -112.1 76.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -87.51 118.95 27.32 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.182 -0.949 . . . . 0.0 109.881 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 2.9 p -83.1 126.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 123.653 1.692 . . . . 0.0 111.814 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.625 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -132.72 -53.16 0.93 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 175.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.732 177.569 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.712 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.795 ' HE1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.801 0.81 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.778 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.6 OUTLIER -167.02 140.42 3.66 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.427 -174.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' SER . 11.5 t -157.39 -44.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -104.82 130.64 52.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.308 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -98.96 114.39 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.581 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 15.5 t0 -95.08 108.59 20.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.097 -1.002 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.99 -65.69 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.365 -0.834 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.74 -29.81 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.526 -0.734 . . . . 0.0 109.398 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -80.1 -41.33 25.74 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.965 ' SG ' ' HB3' ' A' ' 32' ' ' ALA . 13.6 t -54.57 152.93 6.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -138.29 40.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.144 . . . . 0.0 110.112 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 35.24 48.62 0.83 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 1.9 p -78.02 -44.54 26.2 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.28 -1.13 . . . . 0.0 110.082 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 104.99 48.11 1.1 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.671 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 10.4 t -117.14 -2.89 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.186 -1.185 . . . . 0.0 109.967 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 1.5 p -96.95 -69.3 0.76 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.829 -1.169 . . . . 0.0 111.909 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -41.43 -55.5 2.78 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.778 -1.201 . . . . 0.0 109.904 -178.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -40.13 -56.9 1.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.732 -0.605 . . . . 0.0 111.751 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.991 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -60.65 -51.02 71.17 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.924 -1.11 . . . . 0.0 111.277 -177.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.896 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.0 131.51 3.24 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 120.479 -1.388 . . . . 0.0 109.412 -175.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 38.8 Cg_endo -71.55 -9.23 24.75 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.296 3.331 . . . . 0.0 112.998 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.82 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 m-20 -69.98 -67.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.742 -1.224 . . . . 0.0 112.991 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.029 HG12 HD21 ' A' ' 41' ' ' LEU . 2.6 p -112.66 -22.45 4.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 121.368 -0.833 . . . . 0.0 111.17 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.991 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.59 58.42 2.73 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 119.278 -0.969 . . . . 0.0 108.545 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -143.15 91.41 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -149.91 124.13 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.372 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 31' ' ' LYS . . . 173.99 34.37 0.04 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -60.77 -73.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 51.7 t0 -75.15 -24.46 57.94 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.149 -0.969 . . . . 0.0 109.75 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.54 -13.2 1.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' CD ' ' HD3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -83.07 139.56 33.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 109.129 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.965 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -126.3 88.89 2.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HD3' ' CD ' ' A' ' 31' ' ' LYS . 1.1 pttm -113.88 -158.29 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.996 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 p -88.8 143.85 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.909 -1.12 . . . . 0.0 109.414 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.82 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -104.58 -37.75 7.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.64 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -101.9 138.85 19.91 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.387 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.9 Cg_endo -79.28 -76.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.196 2.598 . . . . 0.0 111.105 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.39 54.68 3.13 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.45 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.833 ' OG1' HG11 ' A' ' 23' ' ' VAL . 2.8 t -57.38 101.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.376 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -89.26 -12.43 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.517 -0.739 . . . . 0.0 109.352 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.029 HD21 HG12 ' A' ' 23' ' ' VAL . 1.2 pp -40.94 159.88 0.15 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.0 5.34 6.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.516 2.144 . . . . 0.0 109.652 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.763 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.74 -17.15 24.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.204 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -91.44 -7.47 50.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 119.892 -1.755 . . . . 0.0 110.316 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -61.82 -45.97 91.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -38.73 33.4 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.875 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -47.44 -28.88 2.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.037 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -61.16 -50.44 73.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.261 -0.899 . . . . 0.0 108.621 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -1.53 23.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.374 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -103.35 -82.04 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.935 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.479 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 48.6 t -41.66 100.5 0.22 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.719 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 50' ' ' SER . 37.0 Cg_endo -81.32 6.82 5.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.46 2.107 . . . . 0.0 110.037 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 ' HA ' ' A' ' 10' ' ' CYS . 21.3 p -103.01 12.44 36.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.863 . . . . 0.0 110.564 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 35.62 41.53 0.39 Allowed Glycine 0 N--CA 1.499 2.865 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.51 -19.44 26.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.313 -0.522 . . . . 0.0 109.884 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 34' ' ' VAL . 4.9 pt -109.4 85.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -89.61 117.82 28.77 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.213 -0.929 . . . . 0.0 111.278 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.697 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 3.6 p -81.65 113.59 21.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 123.031 1.396 . . . . 0.0 110.805 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.5 mt-10 -116.87 55.93 0.82 Allowed 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.748 -177.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.671 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.654 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.596 0.712 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.956 ' HZ2' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -165.69 150.56 8.66 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.483 -175.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.3 p -156.31 -44.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.577 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -130.94 167.93 18.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.978 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.089 HG22 HG12 ' A' ' 34' ' ' VAL . 24.8 t -107.35 129.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.494 -0.754 . . . . 0.0 109.823 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 21.2 t0 -92.0 105.35 17.62 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.17 -0.956 . . . . 0.0 108.832 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.32 1.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.893 . . . . 0.0 109.659 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.73 -25.26 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.677 -0.639 . . . . 0.0 109.45 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . . . -85.89 -54.72 4.33 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 110.67 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HA ' HG21 ' A' ' 53' ' ' THR . 44.1 t -50.48 151.15 2.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.865 -1.147 . . . . 0.0 109.989 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' GLY . 3.1 mt -139.98 35.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 40.23 67.27 0.7 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.1 p -104.03 -45.84 4.63 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.194 -1.18 . . . . 0.0 110.028 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 106.97 47.59 1.01 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.623 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.678 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 3.7 t -115.84 2.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.144 -1.209 . . . . 0.0 109.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.645 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -98.82 -80.71 0.46 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.977 -1.077 . . . . 0.0 112.796 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 13.0 pt-20 -39.37 -47.6 1.78 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.54 -1.35 . . . . 0.0 110.513 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.563 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -41.34 -50.23 3.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.678 -0.639 . . . . 0.0 112.389 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -78.99 -48.88 13.64 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 110.897 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.708 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -161.71 107.94 1.18 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 109.042 -176.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HB2' ' NE2' ' A' ' 25' ' ' GLN . 33.2 Cg_endo -66.29 -16.86 53.07 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 123.458 2.772 . . . . 0.0 112.539 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.84 ' HB3' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -50.15 -48.17 53.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.868 -1.145 . . . . 0.0 110.212 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.103 ' CG1' HD21 ' A' ' 41' ' ' LEU . 5.7 p -124.87 -51.24 2.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 O-C-N 121.695 -0.628 . . . . 0.0 110.353 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.871 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -87.76 96.93 10.63 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.241 178.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' HA ' ' CA ' ' A' ' 17' ' ' GLU . 9.4 tt0 -126.53 -142.74 0.29 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.286 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -142.86 122.85 13.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.053 . . . . 0.0 109.632 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 26' ' ' LEU . . . -63.92 -157.79 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -111.02 -32.87 6.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -1.121 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -64.92 -30.0 70.97 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.18 -34.75 2.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 137.89 53.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -1.142 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' CB ' ' S4 ' ' A' ' 61' ' ' SF4 . . . -93.73 114.53 26.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.494 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.971 ' CB ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -123.36 158.55 30.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.597 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.089 HG12 HG22 ' A' ' 5' ' ' VAL . 9.1 p -67.1 135.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.024 -1.048 . . . . 0.0 109.686 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.66 -34.81 10.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -103.64 125.87 33.59 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.802 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 32.7 Cg_endo -77.09 -68.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 123.14 2.56 . . . . 0.0 108.526 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -86.81 60.32 6.15 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.956 HG21 ' HZ2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -56.86 110.21 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.061 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 2.37 45.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.63 -0.668 . . . . 0.0 109.292 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.103 HD21 ' CG1' ' A' ' 23' ' ' VAL . 3.4 pp -64.9 140.58 98.13 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -71.81 -6.02 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.11 1.873 . . . . 0.0 109.45 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.718 ' HB2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.08 -13.99 59.66 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.015 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.702 ' H ' HD12 ' A' ' 41' ' ' LEU . . . -91.07 -11.0 40.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.226 -1.546 . . . . 0.0 110.371 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -47.78 84.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -37.48 36.02 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.097 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -51.45 -25.84 7.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.387 -0.821 . . . . 0.0 109.43 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.99 92.21 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.128 -0.983 . . . . 0.0 109.031 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.11 47.87 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.456 -0.777 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 4.1 m -94.61 -89.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' SG ' ' OG1' ' A' ' 53' ' ' THR . 50.9 t -40.36 100.96 0.23 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.525 -0.734 . . . . 0.0 109.827 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.2 Cg_endo -77.74 -9.6 17.05 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.443 2.095 . . . . 0.0 110.198 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.701 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 51.3 p -82.96 6.18 19.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.3 -0.875 . . . . 0.0 109.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.13 45.3 0.43 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -88.72 6.27 39.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.469 0.652 . . . . 0.0 110.476 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 2' ' ' LYS . 1.9 pt -120.48 90.57 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 3' ' ' VAL . 8.5 t -89.15 118.75 29.07 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.934 -1.104 . . . . 0.0 111.049 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 6.1 p -85.36 120.7 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.036 1.398 . . . . 0.0 111.998 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.647 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -119.47 -50.67 2.32 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 174.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.718 177.604 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.701 ' S3 ' ' CG2' ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.653 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.546 0.689 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 39' ' ' THR . 0.1 OUTLIER -164.06 148.39 10.06 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.174 -175.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.649 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 p -156.37 -44.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.586 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 ptp85 -121.54 144.25 48.83 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 34' ' ' VAL . 4.7 m -102.98 123.63 56.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.579 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.503 ' CG ' ' CB ' ' A' ' 9' ' ' ALA . 23.6 t0 -92.71 110.29 21.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . . . -81.66 -65.47 1.01 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.556 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.16 -27.4 0.6 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.648 0.737 . . . . 0.0 109.022 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -80.02 -42.59 23.53 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.526 -0.734 . . . . 0.0 109.865 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 53' ' ' THR . 40.6 t -66.11 147.59 53.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' O ' ' C ' ' A' ' 12' ' ' GLY . 1.1 mt -139.62 35.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.935 . . . . 0.0 109.565 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 41.32 61.06 2.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 5.4 p -95.32 -46.4 6.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.315 -1.109 . . . . 0.0 110.364 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 112.98 42.26 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.23 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.711 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -107.96 -4.98 10.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.232 -1.158 . . . . 0.0 108.985 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.611 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.3 p -104.8 -49.15 3.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.0 109.615 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -44.0 37.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 10.4 p30 -65.73 -45.35 83.01 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.5 mt -47.52 -82.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.6 0.714 . . . . 0.0 110.4 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -154.91 142.55 14.01 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.543 -0.723 . . . . 0.0 109.085 -177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 37.0 Cg_endo -70.62 -15.43 33.86 Favored 'Trans proline' 0 C--N 1.297 -2.172 0 C-N-CA 124.434 3.423 . . . . 0.0 112.156 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.659 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.1 m-20 -67.83 -57.01 7.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.09 -1.006 . . . . 0.0 111.871 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG12 HD21 ' A' ' 41' ' ' LEU . 4.1 p -121.88 -27.27 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -94.82 49.16 1.22 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.507 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.39 94.55 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 110.333 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 33' ' ' LYS . 39.8 tp -133.03 -88.67 0.42 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.187 -0.945 . . . . 0.0 109.162 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 40.15 39.32 1.51 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -80.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.079 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.46 -18.9 58.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.329 -0.857 . . . . 0.0 109.305 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 -28.86 1.08 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HD3' ' CG ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -74.05 127.31 32.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -1.115 . . . . 0.0 109.364 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -100.05 86.65 3.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.554 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' CG ' ' HD3' ' A' ' 31' ' ' LYS . 1.1 mmmm -105.84 -149.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 5' ' ' VAL . 8.5 p -97.88 138.57 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.652 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -100.98 -33.83 10.02 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.85 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -113.48 134.86 21.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.091 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -78.43 -73.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.943 2.429 . . . . 0.0 110.76 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -88.59 56.82 3.93 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.654 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.716 HG21 ' HB2' ' A' ' 44' ' ' ALA . 1.4 t -55.49 113.08 1.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.123 -1.431 . . . . 0.0 108.202 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -88.89 -19.96 25.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.006 -1.059 . . . . 0.0 108.181 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 HG12 ' A' ' 23' ' ' VAL . 1.4 pp -40.33 161.24 0.11 Allowed Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.856 -0.527 . . . . 0.0 110.124 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 40.1 Cg_endo -86.06 5.87 5.78 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.031 2.487 . . . . 0.0 110.064 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -94.56 -8.78 37.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.082 -1.011 . . . . 0.0 111.405 -178.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.38 -14.32 26.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.298 -1.501 . . . . 0.0 109.784 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -47.43 86.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.33 -37.21 57.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.551 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.26 -36.44 2.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.75 76.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.222 -0.924 . . . . 0.0 108.743 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -79.1 -2.23 39.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.292 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 64.7 m -103.9 -81.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.535 ' N ' HG11 ' A' ' 15' ' ' VAL . 54.1 t -42.9 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.6 Cg_endo -77.63 4.59 5.88 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.511 2.14 . . . . 0.0 110.341 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.69 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 62.7 p -104.84 12.21 32.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 30.52 43.47 0.07 OUTLIER Glycine 0 N--CA 1.503 3.138 0 N-CA-C 107.774 -2.131 . . . . 0.0 107.774 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' THR . . . -89.12 -3.19 58.72 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.096 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' HB ' ' CE ' ' A' ' 2' ' ' LYS . 2.3 pt -118.97 83.18 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -88.33 119.58 28.88 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.198 -0.939 . . . . 0.0 110.452 -178.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 1' ' ' MET . 4.2 p -84.26 119.39 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 122.863 1.316 . . . . 0.0 111.789 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB2' ' CB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -116.68 58.11 0.77 Allowed 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 1.8 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.753 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.711 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.683 ' C ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.382 0.61 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.83 ' HD2' HG21 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -166.34 159.19 14.58 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 118.891 -1.124 . . . . 0.0 112.298 -175.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 57' ' ' SER . 2.7 p -155.06 -45.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -139.8 174.87 10.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.131 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 33' ' ' LYS . 8.8 p -123.59 143.27 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.989 -1.07 . . . . 0.0 109.91 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 32.5 t0 -103.32 123.44 46.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.181 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.243 -0.911 . . . . 0.0 109.748 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -27.28 0.66 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . . . -81.84 -42.47 19.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.962 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' O ' HD13 ' A' ' 11' ' ' ILE . 28.2 t -69.59 150.92 46.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 10' ' ' CYS . 6.7 mm -138.66 38.91 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.94 . . . . 0.0 109.809 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.27 59.56 1.2 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 2.7 p -93.47 -46.63 7.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.181 -1.188 . . . . 0.0 110.358 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.69 43.98 1.0 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.711 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 1.0 OUTLIER -109.28 -3.77 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.055 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 24' ' ' PHE . 2.5 p -104.8 -54.24 2.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.021 . . . . 0.0 110.14 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.1 tt0 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.094 -1.003 . . . . 0.0 108.613 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.7 p30 -63.95 -46.74 83.33 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 47' ' ' ALA . 5.8 mt -47.24 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.967 0.889 . . . . 0.0 109.926 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -154.3 139.94 12.31 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' O ' HD21 ' A' ' 35' ' ' LEU . 35.8 Cg_endo -69.14 -15.68 39.58 Favored 'Trans proline' 0 C--N 1.296 -2.196 0 C-N-CA 124.071 3.18 . . . . 0.0 111.071 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -60.37 -59.84 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.459 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 ' HD2' ' A' ' 2' ' ' LYS . 7.6 p -127.26 -16.37 2.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-O 121.367 0.603 . . . . 0.0 110.609 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.848 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -102.35 84.32 2.45 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.282 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tt0 -145.2 -148.43 0.24 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.154 -0.966 . . . . 0.0 109.385 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -109.18 166.67 10.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.52 -114.13 3.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -102.22 -38.34 7.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -1.156 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -124.93 -164.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.35 -31.93 3.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -53.22 125.8 18.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -1.175 . . . . 0.0 109.643 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.5 92.78 4.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.902 ' CB ' HG21 ' A' ' 5' ' ' VAL . 3.0 ptpt -101.01 -172.55 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.293 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 5' ' ' VAL . 7.3 p -85.78 137.69 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.175 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -97.36 -35.27 10.75 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.648 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -106.76 140.34 21.26 Favored Pre-proline 0 C--N 1.297 -1.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.83 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 37.4 Cg_endo -80.66 -77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.026 2.484 . . . . 0.0 110.913 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -88.93 54.76 3.11 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.55 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 39' ' ' THR . 11.7 t -57.39 97.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.452 -1.299 . . . . 0.0 108.765 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.73 7.43 36.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 109.306 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.608 HD11 ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -65.46 163.14 35.66 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.328 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 36.6 Cg_endo -78.65 3.91 6.86 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.273 1.982 . . . . 0.0 109.373 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.5 m -85.43 -20.56 29.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.848 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -92.14 -19.88 21.82 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.704 -1.248 . . . . 0.0 110.064 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -49.01 75.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -74.14 -35.97 64.12 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.639 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.853 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.11 -33.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 108.933 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.58 -52.19 66.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.62 -8.01 54.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.507 -0.745 . . . . 0.0 109.142 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -101.57 -85.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.695 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.564 ' N ' HG11 ' A' ' 15' ' ' VAL . 45.1 t -42.56 102.5 0.27 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.7 Cg_endo -80.32 7.47 4.72 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.477 2.118 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.684 ' CG2' ' S3 ' ' A' ' 61' ' ' SF4 . 45.8 p -107.49 3.97 25.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 110.451 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 37.1 42.49 0.8 Allowed Glycine 0 N--CA 1.5 2.935 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' VAL . . . -90.37 5.54 46.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.285 0.565 . . . . 0.0 110.397 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HB ' ' HE2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -122.98 89.54 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -88.31 120.3 29.54 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.14 -0.975 . . . . 0.0 110.404 -177.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.683 ' HB ' ' C ' ' A' ' 1' ' ' MET . 7.0 p -86.51 123.07 39.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 122.596 1.188 . . . . 0.0 111.983 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.41 -54.57 2.57 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 102.618 -3.104 . . . . 0.0 102.618 174.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.744 177.681 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.711 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.657 ' CB ' ' HB ' ' A' ' 58' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.727 0.775 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.806 ' HZ2' HG21 ' A' ' 39' ' ' THR . 2.6 ttmt -166.46 38.04 0.05 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 C-N-CA 116.956 -1.898 . . . . 0.0 113.646 -173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 60' ' ' GLU . 57.5 t -87.83 -19.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 109.104 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -92.5 99.6 12.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 5' ' ' VAL . 6.0 m -91.34 114.6 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.97 . . . . 0.0 110.104 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' ALA . 19.8 t0 -104.51 102.13 11.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.414 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 31' ' ' LYS . . . -86.22 -64.92 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 110.266 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.08 -26.65 0.47 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.57 -0.706 . . . . 0.0 109.413 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' CB ' ' CG ' ' A' ' 6' ' ' ASP . . . -79.15 -43.47 23.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.569 -0.707 . . . . 0.0 109.821 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.593 ' CA ' HG21 ' A' ' 53' ' ' THR . 29.7 t -50.29 154.02 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.605 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 12' ' ' GLY . 6.7 pt -143.31 39.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 37.11 53.11 1.6 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.0 p -84.71 -46.09 11.78 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.167 -1.196 . . . . 0.0 110.162 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 110.27 44.14 1.02 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.708 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 0.9 OUTLIER -109.1 -7.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.359 -1.083 . . . . 0.0 109.078 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' CB ' ' HB3' ' A' ' 24' ' ' PHE . 2.6 p -103.55 -45.62 4.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.001 -1.062 . . . . 0.0 109.514 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.93 -48.84 60.64 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 15' ' ' VAL . 9.5 p30 -61.48 -44.68 96.65 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 47' ' ' ALA . 6.8 mt -47.49 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.736 0.779 . . . . 0.0 110.044 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -154.59 140.97 13.0 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 36.8 Cg_endo -70.24 -15.41 35.28 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 C-N-CA 124.281 3.321 . . . . 0.0 111.563 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.804 ' O ' HD21 ' A' ' 35' ' ' LEU . 1.3 m-20 -63.19 -60.09 3.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.072 -1.018 . . . . 0.0 111.033 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.951 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -122.5 -26.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.464 -0.772 . . . . 0.0 111.239 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -91.94 50.58 1.69 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.915 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -149.4 113.98 5.3 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.108 -0.995 . . . . 0.0 109.761 179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -139.43 -79.67 0.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . 41.75 36.01 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -64.82 0.74 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -125.13 32.98 5.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.58 -29.21 8.79 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HD3' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.73 134.36 33.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 109.292 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.627 ' O ' ' S2 ' ' A' ' 61' ' ' SF4 . . . -105.56 78.48 1.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.608 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.23 165.66 12.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.009 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.954 ' HB ' HG22 ' A' ' 56' ' ' ILE . 11.5 p -66.56 142.93 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.042 -1.036 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -100.85 -38.84 8.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.621 ' CB ' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -100.51 140.53 21.48 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.379 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 36.7 Cg_endo -79.99 -76.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.961 2.44 . . . . 0.0 111.588 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.14 52.65 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.874 ' OG1' HG11 ' A' ' 23' ' ' VAL . 6.0 t -58.58 101.54 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.792 -1.163 . . . . 0.0 108.805 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -89.59 -9.82 48.31 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -42.0 163.62 0.12 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.45 -0.781 . . . . 0.0 109.542 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.2 Cg_endo -80.24 4.99 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.534 2.156 . . . . 0.0 109.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 1.8 m -90.9 -21.34 21.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.379 -0.826 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -90.44 -11.15 41.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.604 -1.31 . . . . 0.0 110.019 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -46.91 88.55 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -77.01 -37.42 55.04 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.606 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.849 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . -44.52 -36.46 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.799 . . . . 0.0 109.305 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.14 78.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -2.14 39.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.448 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 15' ' ' VAL . 2.3 t -106.21 -79.13 0.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.568 ' N ' HG11 ' A' ' 15' ' ' VAL . 47.0 t -46.6 104.36 0.4 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.873 -1.142 . . . . 0.0 109.958 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 50' ' ' SER . 36.6 Cg_endo -80.81 -4.31 12.73 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.375 2.05 . . . . 0.0 109.225 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.994 HG22 ' HB2' ' A' ' 55' ' ' ALA . 1.8 m -81.69 -4.22 55.67 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.683 -0.636 . . . . 0.0 109.846 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 46.58 38.08 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.994 ' HB2' HG22 ' A' ' 53' ' ' THR . . . -89.23 -48.37 7.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.954 HG22 ' HB ' ' A' ' 34' ' ' VAL . 14.8 pt -87.31 68.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 2.0 t -91.38 147.32 23.12 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.366 1.079 . . . . 0.0 112.01 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 58' ' ' VAL . 3.9 p -85.93 93.98 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 122.016 0.913 . . . . 0.0 110.495 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -93.29 -43.4 8.82 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 103.223 -2.881 . . . . 0.0 103.223 174.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 3' ' ' VAL . 1.7 tp10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.747 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.708 ' S1 ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.692 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 7.3 tpt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 122.052 0.93 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.981 ' HE2' HG21 ' A' ' 39' ' ' THR . 0.0 OUTLIER -163.77 139.38 6.39 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.559 -175.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 57' ' ' SER . 3.9 m -155.04 -36.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.125 -0.985 . . . . 0.0 109.017 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.573 ' HG3' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -120.81 131.82 54.67 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.753 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 34' ' ' VAL . 6.4 m -94.27 130.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 26.4 t0 -94.66 107.16 19.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.98 . . . . 0.0 109.268 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' ASP . . . -86.41 -65.27 1.03 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 110.094 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 6' ' ' ASP . 1.3 p30 -45.21 -27.46 0.63 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.319 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' CG ' ' A' ' 6' ' ' ASP . . . -88.86 -36.31 16.07 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.491 -0.756 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.489 ' HA ' HG21 ' A' ' 53' ' ' THR . 16.9 t -67.61 156.15 37.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 11' ' ' ILE . 17.2 tt -150.64 40.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 11' ' ' ILE . . . 38.86 31.81 0.15 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 14' ' ' GLY . 3.7 p -57.27 -44.82 84.29 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 13' ' ' CYS . . . 107.78 46.02 1.07 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.534 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.678 ' HB ' ' S1 ' ' A' ' 61' ' ' SF4 . 8.3 t -115.74 -1.8 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -1.231 . . . . 0.0 109.825 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.638 ' HB2' ' CB ' ' A' ' 24' ' ' PHE . 1.5 p -97.14 -71.82 0.67 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.908 -1.12 . . . . 0.0 111.551 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -37.26 -56.3 0.96 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.898 -1.126 . . . . 0.0 109.796 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -40.07 -56.42 1.87 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.745 -0.597 . . . . 0.0 111.5 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -61.4 -50.48 72.66 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 120.869 -1.144 . . . . 0.0 111.081 -177.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.881 ' HB2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -162.05 128.14 2.35 Favored Pre-proline 0 C--N 1.294 -1.809 0 O-C-N 120.471 -1.393 . . . . 0.0 109.406 -175.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 38.1 Cg_endo -70.93 -10.08 26.94 Favored 'Trans proline' 0 C--N 1.293 -2.38 0 C-N-CA 124.099 3.199 . . . . 0.0 112.664 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -68.84 -61.17 1.92 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.123 . . . . 0.0 113.02 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.068 HG12 HD21 ' A' ' 41' ' ' LEU . 3.0 p -119.34 -25.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 120.994 -1.066 . . . . 0.0 111.189 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 1.03 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.52 90.57 4.8 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.411 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 tt0 -129.79 -144.78 0.27 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.206 -0.934 . . . . 0.0 109.321 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 26' ' ' LEU . 2.0 pp -138.6 173.63 11.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.76 155.64 15.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -63.97 -41.07 97.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -13.63 54.32 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.55 -39.4 2.9 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.09 120.36 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -1.09 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -94.36 77.01 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -92.87 179.92 5.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.042 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.909 HG12 HG12 ' A' ' 5' ' ' VAL . 9.4 p -72.89 144.72 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.984 -1.073 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.768 HD11 ' OE1' ' A' ' 36' ' ' GLN . 0.2 OUTLIER -103.92 -37.78 7.27 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.768 ' OE1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -97.91 147.48 33.12 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.62 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' A' ' 36' ' ' GLN . 39.3 Cg_endo -83.84 -79.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.254 2.636 . . . . 0.0 110.747 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.06 60.61 5.9 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.981 HG21 ' HE2' ' A' ' 2' ' ' LYS . 2.4 t -57.4 97.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.86 -1.136 . . . . 0.0 109.32 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -91.16 -10.69 40.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.068 HD21 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -42.72 159.98 0.2 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 41' ' ' LEU . 37.7 Cg_endo -81.52 4.68 6.82 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.596 2.197 . . . . 0.0 109.344 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.654 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.5 -14.98 27.65 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.451 -178.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.81 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -93.39 -3.61 52.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.205 -1.56 . . . . 0.0 109.998 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.01 77.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -31.83 22.27 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.018 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . . . -57.55 -28.59 63.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.019 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.24 73.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.256 -0.903 . . . . 0.0 108.664 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.68 -21.0 61.86 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.447 -0.783 . . . . 0.0 109.227 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.493 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.8 m -80.53 -89.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.78 . . . . 0.0 109.285 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.8 t -39.86 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.487 -0.758 . . . . 0.0 109.273 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 50' ' ' SER . 35.4 Cg_endo -77.63 -4.08 14.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.4 2.066 . . . . 0.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' S3 ' ' A' ' 61' ' ' SF4 . 43.2 p -87.34 10.14 18.23 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 34.39 45.89 0.5 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . . . -90.22 -5.69 56.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 122.33 -0.512 . . . . 0.0 110.746 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 ' HD3' ' A' ' 2' ' ' LYS . 1.8 pt -121.8 79.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.875 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.09 124.44 33.78 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.692 ' CG2' ' HA ' ' A' ' 1' ' ' MET . 2.4 p -84.31 121.0 36.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.587 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.833 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -108.18 -65.35 1.13 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 173.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.865 177.37 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SF4 . . . . . 0.787 ' S3 ' HG21 ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_